这也引出一项新的技术——基因靶向技术。
基因靶向技术的进步，带来了人类改造生命的可能。
Gene targeting technology, has brought the possibility of human transformation of life.
基于该技术设计的首批靶向基因的药物已经在美国开始临床试验了，主要是针对具有动脉疾病和由糖尿病引发的神经损伤的病人。
The first drugs designed to target the genes have begun clinical trials in the United States on patients with arterial disease and diabetes-induced nerve damage.
近几年，国内外学者利用超声联合微泡造影技术所产生的生物学效应，实现了微泡造影剂携载药物和基因对肿瘤的靶向治疗。
Resently years, researchers utilize biological effects generated by microbubble contrast agent combined ultrasound techniques to implement therapy of tumor by microbubble carrying drug and gene.
通过靶向测序和荧光原位杂交技术发现，3例均存在ZC 3h7b -BCOR基因融合。
All 3 ESS were found to harbor ZC3H7B-BCOR gene fusions by targeted sequencing and fluorescence in situ hybridization.
通过靶向测序和荧光原位杂交技术发现，3例均存在ZC 3h7b -BCOR基因融合。
All 3 ESS were found to harbor ZC3H7B-BCOR gene fusions by targeted sequencing and fluorescence in situ hybridization.
应用推荐